An investment research firm wanted to prove AI could revolutionize drug development. So they teamed up with Anthropic to see whether an unreleased version of Claude could make scorpion antivenom. It couldn't. It came up with some promising starting points, but nothing close to an actual drug, experts tell The Verge. Citrini Research, the firm […]
An investment research firm wanted to prove AI could revolutionize drug development. So they teamed up with Anthropic to see whether an unreleased version of Claude could make scorpion antivenom. It couldn't. It came up with some promising starting points, but nothing close to an actual drug, experts tell The Verge. Citrini Research, the firm […]
An investment research firm wanted to prove AI could revolutionize drug development.
So they teamed up with Anthropic to see whether an unreleased version of Claude could make scorpion antivenom.
It came up with some promising starting points, but nothing close to an actual drug, experts tell The Verge.
This story helps build a stronger internal English tech archive around Technology, giving search visitors more reasons to keep browsing the site instead of bouncing after a single headline.